Neuropace, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for NPCE, updated each market day.
NPCE AI Sentiment
AI sees no strong directional signal for Neuropace, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 23, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Neuropace, Inc. Common Stock
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Sector
Exchange
Market Cap
$485,688,477
Cap Tier
Employees
220
Headquarters
MOUNTAIN VIEW, CA
Listed Since
April 22, 2021
Website
NPCE Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NPCE Volatility
Neuropace, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
